Membership

The Working Group is a pathology-driven group of experts, assisted by experts clinicians, scientist and statisticians. The Working Group is open to open to include all pathologists willing to get involved in the activities of the group.

Please send an email to roberto@salgado.be

Information on Membership

    1. Membership of the Working Group is on a voluntary basis.
    2. All members will receive 2-3 times a year a mailing from the chair of the WG with the details of the ongoing projects so that all remain informed.
    3. This communication is done by e-mail and a copy of this mailing is posted on the BLOG of the TIL-website, under the item “Practical Info for all members”.
    4. In order to achieve uniformity in the methodology of scoring TILs worldwide, each member is encouraged to use the Internationally accepted guideline and do their part for promotion and dissemination of the guideline.

The following is a list of current members of the International Immuno-Oncology Working Group (TILs Working Group)*. A member is defined as a person willing to be involved, informed and be part of the activities of the TILs Working Group. The authors alone are responsible for the views expressed in the work of the TILs Working Group and they do not necessarily represent the decisions, policy or views of their employer.

    1. Salgado, Roberto – Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium (Co-Chair, Founder, Core-Group Member)
    2. Loi, Sherene – Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia (Co-Chair, Founder, Core-Group Member)
    3. Denkert, Carsten – Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany (Co-Chair, Founder, Core-Group Member)
    4. Badve, Sunil – Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia; Emory University Winship Cancer Institute, Atlanta, Georgia, USA (Founder, Core-Group Member)
    5. Demaria, Sandra – Department of Pathology, Weill-Cornell Medicine, New York, USA (Founder, Core-Group Member)
    6. Adams, Sylvia – Perlmutter Cancer Center, New York University Medical School, New York, USA; Department of Medicine, NYU Grossman School of Medicine, Manhattan, NY, USA (Founder, Core-Group Member)
    7. Michiels, Stefan – Office of Biostatistics and Epidemiology, Gustave Roussy, Oncostat U1018, Inserm, University Paris-Saclay, Ligue Contre le Cancer labeled Team, Villejuif, France (Founder, Core-Group Member)
    8. Rimm, David – Department of Pathology, Yale University School of Medicine, New Haven, USA (Core-Group Member)
    9. Symmans, Fraser – Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA (Core-Group Member)
    10. Hewitt, Stephen – Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, USA (Core-Group Member)
    11. Bartlett, John – University of Edinburgh, Edinburgh, Scotland, UK (Core-Group Member)
    12. Nielsen, Torsten – Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Core-Group Member)
    13. Sotiriou, Christos – Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium; Medical Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium (Core-Group Member)
    14. Giuseppe Viale, Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy (Core-Group Member)
    15. Pruneri, Giancarlo – Fondazione Istituto di Ricovero e Cura a Carattere Scientifico–Isituto Nazionale dei Tumori, Universita degli Studi di Milano, Milan, Italy (Core-Group Member)
    16. Loibl, Sybille – Department of Medicine and Research, German Breast Group, Neu-Isenburg, Germany (Core-Group Member)
    17. Abbad, FayÇõal – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    18. Abdou, Yara – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    19. Abdulmalik, Omotola – Pathology, University of Cape Town, South Africa;
    20. Abdylkarim, Ali – Icahn School of Medicine, Mount Sinai, New York, USA;
    21. Abe, Norie – Breast Surgery, Nakagami Hospital, Okinawa, Japan;
    22. Abels, Esther – VisioPharm, Colorado, USA;
    23. Aboelnasr, Lamia – Metabolism, digestion and represent, Imperial College London, United Kingdom;
    24. Acosta-Haab, Gabriela – Department of Pathology, Hospital de Oncología Maria Curie, Buenos Aires, Argentina;
    25. Acs, Balazs – Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden;
    26. Adam, Julien – Department of Pathology, Gustave Roussy, Grand Paris, France;
    27. Adam, Peggy – Jules Bordet Institute, Belgium;
    28. Aftimos, Philippe – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    29. Agbor-Tarh, Dominique – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    30. AIT MOULOUD, Makhlouf – Faculté de Médecine, Universite Mouloud MAMMERI, Algeria;
    31. Ajemba, Ogugua – Anatomic Pathology, Q2 Solutions, USA;
    32. Akturk, Guray – Translational Molecular Biomarkers, Merck & Co., Inc., Kenilworth, New Jersey, USA;
    33. al Bakir, Maise – Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK;
    34. Albanell, Joan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    35. Ales, Ales – The Fingerland Department of Pathology, University Hospital Hradec Kralove, Czech Republic;
    36. Alhamad, Balkese – Oncology, king Abdullah international medical research center (KAIMRC), Saudi Arabia;
    37. Alla, Aleksandra – Oncology, QSUT, Albania;
    38. Allison, Kimberly H. – Pathology Department, Stanford University Medical Centre, Stanford, USA;
    39. Almangush, Alhadi – Department of Pathology, University of Helsinki and University of Turku, Finland.;
    40. Almeida, Jonas S. – National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG);
    41. Almeida, Valdivieso – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    42. Alvarado Cabrero, Isabel – Oncology Hospital, Star Medica Centro, Mexico;
    43. Alvarez Retuerto, Ana – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    44. Amat, Mora – IAFleming;
    45. Amendoeira, isabel – Serviço de Anatomia Patológica, Centro Hospitalar Universitario de São João and Ipatimup, Porto, Portugal;
    46. Amendola, Luis Claudio – Brazilian Socity of Oncology;
    47. Amgad, Mohamed – Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA;
    48. aminzadeh, Parisa – Breast Screen ST Vincent, St Vincent Hopsital, Melbourne, Australia;
    49. Amiri Kordestani, Laleh – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    50. Anderson, Joseph – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    51. Andrade Pereira, Renan – Blazar SAS, Paris, France;
    52. Andre, Fabrice – Department of Medical Oncology, Gustave Roussy, Villejuif, France;
    53. Andrea, Joaquin Garcia – Institut Jules Bordet, Belgium;
    54. Angulo, Maria – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    55. Anota Ramirez, Bruno Elias – Pathology, Unidad de Patologia y Reumatologua, Mexico;
    56. Apolinario, Thiago – Department of Oncology, IMIP, Brazil;
    57. Araya, Juan Carlos – Department of Pathology, Universidad de La Frontera, Temuco, Chile;
    58. Arbzadeh, Elham – Department of Pathology, VCU, USA;
    59. Archuleta, Jose – Pathology, Cellcarta, Belgium;
    60. Arun, Indu – Department of Histopathology, Tata Medical Center, Kolkata, India;
    61. Asirvatham, Jaya Ruth – Baylor Scott and White Health System-Central Texas, USA;
    62. Asok, Aneesha – MES medical college, India;
    63. Azmoudeh-Ardalan, Farid – Pathology Department, Tehran University of Medical Sciences, Iran;
    64. Bacha, Naila – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    65. Bachani, Lira – Pathology, Unipath, India;
    66. Baehner, Rick – Genomic Health;
    67. BAGBUDAR, SIDAR – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    68. Bago-Horvath, Zsuzsanna – Department of Pathology, Medical University of Vienna, Vienna, Austria;
    69. baibai, bai – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    70. Balancin, Marcelo – Department of Pathology, Faculty of Medicine, University of São Paulo; São Paulo, Brazil;
    71. Balis, Georgios Christos – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    72. Balko, Justin M. – Departments of Medicine and Cancer Biology, Vanderbilt University Medical Centre, Nashville, USA;
    73. Ballesteros-Merino, Carmen – Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute/Providence Cancer Center, Portland, Oregon, USA;
    74. Balslev, Eva – Department of Pathology, Herlev and Gentofte Hospital, Denmark;
    75. Baltatescu, Gabriela Izabela – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    76. BARADELLO, Pio – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    77. Baretton, Gustavo – Universitätsklinikum Carl Gustav Carus, Germany;
    78. Barnes, Michael – PathAI;
    79. Barros de Oliviera, Francine – Department of Pathology, UFMG, Brazil;
    80. BAUTISTA, VERONICA – Department of Pathology, Breast Cancer Center FUCAM, Mexico City, Mexico;
    81. Baycelebi, deniz – Pathology, Memorial, Turkey;
    82. Beatrice, Belgio – Surgical Pathology, AUSL Imola, Italy;
    83. Beaudry, Jean Bernard – BMS;
    84. Beaver, Julia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    85. Beck, Andrew H. – PathAI, Inc., Cambridge, USA;
    86. Bedri, Shahinaz – Anatomic Pathology, Boston, Massachusetts, USA;
    87. Beer, Philip – Clinical Cancer Genomics, GG&C, NHS, United Kingdom;
    88. Belizario, Jose – School of Arts, Sciences and Humanity, University of Sao Paulo, Brazil;
    89. Bellizzi, Andrew M. – Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, USA;
    90. Bellolio, Enrique – Department of Anatomic Pathology, Faculty of Medicine, Universidad De La Frontera, Temuco Chile; Hospital Dr. Hernán Henríquez Aravena, Temuco Chile.
    91. ben lakhdar, aÇîcha – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    92. Ben Taieb, Aicha – Roche;
    93. Berrevoets, Pieter – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    94. Bethmann, Daniel – University Hospital Halle (Saale), Institute of Pathology, Halle (Saale), Germany;
    95. beurey, philippe – CPEGG, France;
    96. Beziaeva, Liudmila – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    97. Bheemaraju, Vydehi – Department of pathology, Narayana Medical College, Nellore, Andhra Pradesh, India;
    98. Bianchi, Simonetta – Dipartimento di Scienze della Salute (DSS), Firenze, Italy;
    99. Bianchini, Giampaolo – Medical Oncology, San Raffael Scientific Institute, Italy;
    100. BILANCIA, Domenico – Medical Oncology, Azienda Ospedaliera Regionale San Carlo, Italy;
    101. Binczyk, Franciszek – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    102. Bissonnette, Reid – Translational Research, Targazyme, USA;
    103. Blackley, Elizabeth F. – Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
    104. Blenman, Kim R.M. – Department of Internal Medicine Section of Medical Oncology and Yale Cancer Center, Yale School of Medicine, CT, USA;
    105. Bodnar, Lubomir – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    106. Boeckx, Carolien – Roche Diagnostics, Belgium;
    107. Bondanar, Anastasiya – Pathomorphology, Buzoo KOD, Russia;
    108. Bonetto, Sara – U.O. Anatomia Patologica, ASST Lariana-Ospedale “Sant’Anna di Como”, Italy;
    109. Bortesi, Laura – Pathology, IRCCS sacrocuore don calabria, Italy;
    110. Bosco, Florence – BioPark Dev, Belgium;
    111. Bosco, Martino – Pathology, ASLCN2;
    112. Bossuyt, Veerle – Department of Pathology, Massachusetts General Hospital, USA;
    113. Botinelly Mendonça Fujimoto, Luciana – Amazonas Federal University;
    114. Bouchmaa, Najat – Institute of Biological Sciences, Faculty of Medical Sciences, Mohammed VI Polytechnic University (UM6P), 43150 Ben-Guerir, Morocco;
    115. Braybrooke, Jeremy – Nuffield Department of Population Health, University of Oxford, Oxford and Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK;
    116. Brcic, Iva – Institute of Pathology, Medical University of Graz, Austria;
    117. Bria, Emilio – Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, ITALY;
    118. Brock, Jane – Department of Pathology, Brigham and Women’s Hospital, Boston, USA;
    119. Broeckx, Glenn – Department of pathology PA², GZA-ZNA hospitals, Antwerp, Belgium;
    120. Brogi, Edi – Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;
    121. Brown, Mark – Pathology, Q2 Solutions, United Kingdom;
    122. Brunetti, Barbara – Department of veterinary medical sciences, university of Bologna, Italy;
    123. Bui, Marilyn – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    124. Buisseret, Laurence – Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium;
    125. Burchardi, Nicole – German Breast Group GmbH, Germany;
    126. Burger, Franz – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    127. Burgues, Octavio – Pathology department, Hospital Cliníco Universitario de Valencia/Incliva;
    128. Bussola, Nicole – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    129. butera, alfredo – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    130. Caballero, Rosalia – GEICAM, Spain;
    131. Calatrava, Ana – Fundacion Intituto Valenciano de Oncologia, Valencia, Spain;
    132. Calhoun, Benjamin – Department of Pathology and Laboratory Medicine, UNC School of Medicine, USA;
    133. Callagy, Grace – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    134. Cámaea, Vincente Peg – Pathology Department, H.U. Vall d’Hebron, Barcelona, Spain;
    135. Camandola, Simonetta – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    136. Canto, Abaete – Surgical Pathology, SBP;
    137. Cappellesso, Rocco – Pathological Anatomy, Padova University Hospital;
    138. Caramia, Franco – Bioinformatics, Peter MacCallum Cancer Centre, Australia;
    139. Cardoso, Fatima – Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal;
    140. Carey, Caroline – Roche Diagnostics, Belgium;
    141. Carla, Gazzi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    142. Carpentino, Laura – School of Pathology, University of Milan,  Milan, Italy;
    143. carpio, emilio – Biomedicine, universidad ciencias medicas sancti spiritus, cuba;
    144. Carter, Jodi M. – Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA;
    145. CARVALHO, FILOMENA – Department of Pathology, Universidade de Sao Paulo, Brazil;
    146. Caserta, Benedicta – Department of Pathology, Hospital de la mujer. CHPR. /BECOLABS, Uruguay;
    147. cassiano, anita – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    148. Castaneda, Carlos – Department of Research, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú;
    149. Castellano, Isabella – Department of Medical Sciences, University of Turin, Italy;
    150. Castellano, Tibisay – Pathology, Seguro Social, Ecuador;
    151. Castillo, Miluska – Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru;
    152. Cebollero, MarÇða – Pathology Department. Hospital General Universitario Gregorio Marañón. Madrid, Spain.;
    153. Cerna, Abda – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    154. Cerpa, Leslie – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    155. Ceusters, Dorien – KU Leuven, Belgium;
    156. Cha, Yongjun – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    157. Chabaesele, Ronald – Department of Pathology, AGA KHAN UNIVERSITY Hospital, Kenya;
    158. Chacón, Jose Ignacio – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    159. CHAER, YEESOO – Medical Oncology, KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL, South Korea;
    160. Chan, Jack – Department of Oncology, National Cancer Centre, Singapore;
    161. Chardas, Alexandros – Department of Pathobiology & Population Sciences, The Royal Veterinary College, UK;
    162. Chauhan, Cynthia – Mayo Clinic Breast SPORE, Mayo Clinic, Rochester, MN;
    163. Cheang, Maggie – Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, Surrey, UK;
    164. Chen, I-Chun – Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan;
    165. Chen, Weijie – Division of Imaging, Diagnostics, and Software Reliability (DIDSR), Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), Rockville, USA;
    166. Cheng, Sandy – Gleneagles Hong Kong Hospital, Hong Kong;
    167. Chennubhotla, Chakra S. – Department of Computational and Systems Biology, University of Pittsburgh, USA;
    168. Chmielik, Ewa – Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland;
    169. CHOI, HYUN JOO – St. Vincent’s Hospital, The Catholic University of Korea, Seoul, South Korea;
    170. Choi, Junjeong – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    171. Chon U Cheang, Maggie – ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London, UK;
    172. Christie, Michael – Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville, Australia;
    173. Cimino-Mathews, Ashley – Departments of Pathology and Oncology, The Johns Hopkins Hospital, Baltimore, USA;
    174. Ciompi, Francesco – Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands;
    175. Clausen, Signe – Aarhus university, Denmark;
    176. Clunie, David – Consulting, PixelMed, Pennsylvenia, USA;
    177. Coates, Phil – The Journal of Pathology;
    178. Coban, Ipek – Anatomic Pathology, Istanbul Florence Nightingale Hospital;
    179. Cochran, John – Q2 Solutions, Atlanta, GA;
    180. Cockenpot, Vincent – Department of Pathology, Léon Bérard Cancer Center, Lyon, France;
    181. Colliver, Emma – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    182. Colpaert, Cecile – Department of Pathology, AZ Turnhout, Turnhout, Belgium;
    183. Comerma, Laura – Pathology Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain;
    184. Cooper, Lee A. D. – Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL;
    185. Coosemans, An – Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium;
    186. CORPA, MARCUS – Pathology, Hospital israelita Albert Einstein, Afghanistan;
    187. Corredor Prada, German – Biomedical Engineering Department, Emory University, Atlanta-GA, USA;
    188. Corten, Kirsten – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    189. Cortes, Javier – Head breast Cancer Program, Oncology Department, IOB institute of Oncology, Quiron Group;
    190. Cree, Ian – International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France;
    191. Criscitiello, Carmen – Department of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy;
    192. Cserni, Gabor – Department of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary; Department of Pathology, University of Szeged, Szeged, Hungary.;
    193. Cucherousset, Joël – GHI Le Raincy-Montfermeil, Chelles, Île-de-France, France;
    194. Cuesta, RubǸn – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    195. Curigliano, Giuseppe – University of Milano, Istituto Europeo di Oncologia, IRCCS, Milano, Italy;
    196. d’Alfons, Timothy – Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;
    197. Dackus, Gwen – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    198. Dacy, Matthew – Mayo Clinic;
    199. Dahl, Anders – Technical University of Denmark, Kgs. Lyngby, Denmark;
    200. Dantas Portela, Flavio Luis – Departamento de Patologia e Medicina Legal, Hospital Universitário Getúlio Vargas, Brazil;
    201. davies, mary – Research, UM, USA;
    202. Dayananda, Harshitha – Depatment of Pathology, Sri Shankara Cancer Hospital and Research Center, India;
    203. de Cabo, Rafael – Experimental Gerontology Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA;
    204. de Maaker, Michiel – Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
    205. de Paula, Alfredo – Dentistry, Universidade Estadual de Montes Claros (UNIMONTES), Brazil;
    206. De Toro, Gonzalo – Universidad Austral de Chile – Hospital de puerto montt, Chile;
    207. de Wind, Roland – Department of Pathology, Institut Jules Bordet, Brussels, Belgium;
    208. deCabo, Rafa – Experimental Gerontology Section and Translational Gerontology Branch, NIA, NIH, USA;
    209. Decaluwe, Alex – Department of Radiology, Jules Bordet Institute;
    210. Declercq, Sabine – Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium;
    211. DELLA LIBERA, DUILIO – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    212. Deman, Frederik – Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.;
    213. Demichele, Angela – University of Pennsilvania, USA;
    214. Dennis, Eslie – Ventana;
    215. Dent, Rebecca – Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.;
    216. Dequeker, Els – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    217. Desai, Sangeeta – Pathology, Tata Memorial Centre;
    218. Devarakonda, Vaishnavi – Cedars Sinai medical center, USA;
    219. Dey, Sumana – Cancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA; USA
    220. di candia, leonarda – Biologo;
    221. Dieci, Maria Vittoria – Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy;
    222. Dillon, Deborah A. – Department of Pathology, Brigham and Women’s Hospital, Boston, MA Department of Pathology, Dana Farber Cancer Institute, Boston, MA;
    223. DiMaio, Michael – Pathology, DPMG, USA;
    224. Dimitrova, Polina – Department of Pathology, University Hospital, Bulgary;
    225. Dinusha, Pakam – Department of Pathology, Narayana Medical College, Nellore, India;
    226. Dirix, Luc – Medical Oncology, GZA, Antwerp, Belgium;
    227. do prado moura, jose fernando – Centro de Pesquisas Clinicas do IMIP, Brasil;
    228. Dodds, Tristan – Laverty, Australia;
    229. Dogdas, Belma – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    230. Dorca, Eduard – Institute of Oncologia, Barcelona, Spain;
    231. Doré Hansen, Johan – Visiopharm A/S, Hørsholm, Denmark;
    232. Dos Anjo, Carlos – Merck;
    233. Drubay, Damien – Gustave Roussy, Universite Paris-Saclay, Villejuif, France; Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France;
    234. Dudgeon, Sarah – Computational Biology and Bioinformatics, Yale University, CT, USA;
    235. DurÇ­n, Sundry – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    236. Duregon, Eleanora – Experimental Gerontology Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA;
    237. Duregon, Eleonora – National Health Institute, USA;
    238. Durga, Kharidehal – Department of Pathology, Narayana Medical College, Nellore, India;
    239. Duscio, Belinda – Cancer therapeutics and development, Olivia Newton John Cancer research institute, Melbourne, Australia;
    240. Dutulescu, Sorin – Oncoteam Diagnostic, Romania;
    241. Earls, Peter – Anatomical Pathology, St Vincent’s Hospital Sydney, Australia;
    242. Ebstrup, Thomas – Visiopharm A/S, Hørsholm, Denmark;
    243. edirisinghe, amalika – Pathology, NSW Health, Gosford, Australia;
    244. Ehinger, Anna – Department of Clinical Genetics and Pathology, Skåne University Hospital, Lund University, Lund, Sweden;
    245. Eker, GǬlcihan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    246. El Bairi, Khalid – Cancer Biomarkers Working Group, Oujda, Morocco;
    247. El-Abed, Sarra – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    248. Elfer, Katherine – Division of Imaging, Diagnostics, and Software Reliability, US Food and Drug Administration, Silver Spring, MD, USA;
    249. ElGabry, Ehab – Roche, Tucson, USA;
    250. Elghazawy, Mahmoud – University Of Surrey, UK and Ain Shams University, Egypt;
    251. Ellis, Toby – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    252. Elomina, Kevin – Laboratory Medicine, De La Salle University Medical Center, Philippines;
    253. Emancipator, Kenneth – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    254. Emelyanov, Alexander – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    255. Enfield, Katey – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    256. Engelen, Vincent – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    257. Erber, Ramona – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    258. Espejo Herrera, Nadia – Pathology, Consorci Hospitalari de Vic, Spain;
    259. Estrada, M. Valeria – Biorepository and Tissue Technology Shared Resources, University of California San Diego, USA;
    260. Fadare, Oluwole – Division of Anatomic Pathology, University of California San Diego Health System;
    261. Falo Zamora, Catalina – Institute of Oncologia, Barcelona, Spain;
    262. Fan, Fang – Department of Pathology, University of Kansas Medical Center, USA;
    263. Fang, Yisheng – Pathology, UT Southwestern Medical Center in Dallas, USA;
    264. Farshid, Gelareh – Directorate of Surgical Pathology, SA Pathology, Adelaide, Australia;
    265. Federmann, Birgit – Pathology, University of Tübingen, Denmark;
    266. Feinman, Rena – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    267. Felip, Eudald – Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.;
    268. Fernandez Martin, Claudio – Instituto Universitario de Investigación en Tecnología Centrada en el Ser Humano, HUMAN-tech, Universitat Politècnica de València, Valencia, Spain;
    269. Ferreira Pinheiro, Jorge Adriano – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    270. Figueiredo, Paulo – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    271. Filip, Madalin-Cosmin – Pathology,Colentina Clinical Hospital, Romania;
    272. Fine, Jeffrey – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    273. Fineberg, Susan – Department of Pathology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, United States; Albert Einstein College of Medicine, United States
    274. Firer, Michael – Adelson School of Medicine, Ariel University, Israel;
    275. Flanagan, Adrienne – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    276. Fleet, Luke – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    277. Fleischhacker, Adam – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    278. Flores-Villanueva, Pedro – Translational Immuno-Oncology, Peruvian NIH, Peru;
    279. Floris, Giuseppe – KU Leuven- Univerisity of Leuven, Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research and KU Leuven- University Hospitals Leuven, Department of Pathology, Leuven, Belgium;
    280. Flowers, Margaret – Breast Cancer Research Foundation, New York, NY, USA;
    281. Fong, Jacinta – Harry Perkins Institute of Medical Research, University of Western Australia;
    282. Foschini, Maria Pia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    283. Fox, Stephen B. – Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
    284. Frahm, Isabel – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    285. Frahm, Isabel – Department of Pathology, Sanatorio Mater Dei, Buenos Aires, Argentina;
    286. Francis, Prudence A. – Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia;
    287. Franzoi, Maria Alice – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    288. Freitas, Juliana – Pathology Department, Federal University of Bahia, Brazil;
    289. Fuchs, Talia – NSW Health Pathology, Sydney, Australia;
    290. Fujimoto, Luciana – Pathology and Legal Medicine, Amazon Federal University, Brasil;
    291. Fuks, Francois – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    292. Fula, Carolina – Pathology, Hospital de Móstoles, Spain;
    293. Fulop, Annamaria – Anatomical Pathology, The Oncology Institute Cluj-Napoca, Romania;
    294. G, Unnikrishnan – Pathology, Government medical College Ernakulam, Kerala India;
    295. Gaboury, Louis – Department of Pathology and Cell Biology, Faculty of Medicine, Montreal University, Canada;
    296. Gaire, Fabien – Pathology and Tissue Analytics, Roche;
    297. Galas, Kristin – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    298. Galeano Reyes, Silvio Antonio – Anatomical Pathology, HUFA, Spain;
    299. Gallagher, William – UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland;
    300. Gallas, Brandon – Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA;
    301. Galvao, Vladimir – Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology, Spain;
    302. Ganshina, Inna – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    303. Gao, George – Pathology, Stanford University, USA;
    304. Garcia, Felip – Pathology Department, Hospital Quiron Salud;
    305. Garcia, Victor – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    306. Garcia Rivello, Hernan – Anatomical Pathology, Hospital Italiano de Buenos Aires, Argentina.;
    307. garcia-murillas, isaac – Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK;
    308. Garrido Castro, Ana C. – Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.;
    309. Garufi, Giovanna – Medical Oncology Unit, Agistino Gemelli IRCCS Polyclinic Foundation, Rome, Italy.;
    310. Gazinska, Patrycja – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    311. Gebremariam, Tewodros – Pathology, Addis Ababa University, College of Health Sciences, Ethiopia;
    312. Gevaert, Thomas – Department of Development and Regeneration, Laboratory of Experimental Urology, KU Leuven, Leuven, Belgium;
    313. Gharib, Masoumeh – Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;
    314. Ghysels, Tom – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    315. Giacometti, Cinzia – Department of Pathology, ULSS 6 Euganea, Italy;
    316. Gianni, Lorenzo – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    317. Giannone, Antonino Giulio – Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Italy;
    318. Giannotti, Mag – Pathology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil;
    319. Gilham, Leslie – Consumer Advisory Panel, Breast Cancer Trials;
    320. Gill, Anthony – University of Sydney, Sydney, Australia;
    321. Giltnane, Jennifer – Research Pathology, Genentech Inc., South San Francisco, USA;
    322. Gluz, Oleg – Johanniter GmbH – Evangelisches Krankenhaus Bethesda Mönchengladbach, West German Study Group, Mönchengladbach, Germany;
    323. Gnjatic, Sacha – Deparment of Oncological Sciences, Medicine Hem/Onc, and Pathology, Tisch Cancer Institute – Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA;
    324. GODOY, ANA – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    325. Goel, Shom – Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;
    326. Goetz, Matthew P. – Department of Oncology, Mayo Clinic, Rochester, USA;
    327. Goleij, Pouya – Sana Institute of Higher Education, Sari, Iran;
    328. Gondra, Helena – Pathology, Sheba, Tel Hashomer, Israel;
    329. Gong, Gyungyub – Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Korea;
    330. Gonzalez Carril, Fernando – Pathology, Ribera Povisa, Spain;
    331. Gonzalez Ericsson, Paula – Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA;
    332. Goswami, Hansa – Department of Pathology, BJ Medical College, Ahmedabad, India;
    333. Gouasmia, Adel – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    334. Gouda, Isabelle – Patient Advocate, Romania;
    335. Gown, Allen – PhenoPath Laboratories, Seattle, USA;
    336. Grantham, Mica – Pathology, Howard University Hospital, USA;
    337. Grigoriadis, Anita – Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK; The Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
    338. Grimm, Oliver – Pathology and Tissue Analytics, Roche;
    339. Groen, Emilie – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    340. Grubert, Neil – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    341. Grubišić, Danijel Antonio – Pathology and citology, University hospital center Split, Croatia;
    342. Gruosso, Tina – Translational Research,  Forbius, Montreal, Canada;
    343. Gualtieri, Giovanna – Knowledge & Information Management, Novartis, USA;
    344. Guerra, Ana – Pathology, GMSP, Venezuela;
    345. Guerrero, Angel – Department of Oncology, IVO Valencia, Spain;
    346. GULERIA, PRERNA – Army Hospital Research and Referral, Delhi Cantt, New Delhi, India; Oncopathologist
    347. Gupta, Rajarsi – Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA;
    348. gupta, rashi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    349. Hagen, Carlos – Palex Medical SA – Exact Sciences Corp, Spain;
    350. Haibe-Kans, Benjamin – Bioinformatics and Computational Genomics Laboratory, Princess Margaret Cancer Center, Toronto, Canada;
    351. Hainfellner, Johannes – Department of Medicine, Clinical Division of Oncology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria;
    352. Halama, Niels – Department of Translational Immunotherapy, German Cancer Research Center, Heidelberg, Germany;
    353. Hall, Jacqueline A. – Vivactiv Ltd, Bellingdon, Bucks, UK;
    354. Hall, Sean – The Gillies McIndoe Research Institute, Wellington, NZ;
    355. Hamada, Tetsuo – Department of Surgical Pathology, JR Kyushu Hospital, Kitakyushu, Fukuoka, Japan;
    356. Han, Eunkyung – Pathology, SNUBH, South Korea;
    357. Hanane, Akli – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    358. Hanna, Matthew G. – Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;
    359. Harbeck, Nadia – Breast Center, Dept. OB&GYN and CCC (LMU), University of Munich, Munich, Germany;
    360. Harbhajanka, Aparna – Case western University, Cleveland, OH;
    361. Harris, Gavin – Canterbury Health Laboratories;
    362. Hart, Steven N. – Department of Laboratory Medicine and Pathology, Mayo Clinic, United States;
    363. Hartman, Johan – Deptartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden;
    364. HATIPOGLU, NUH – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    365. Hauberg, Søren – Technical University of Denmark, Kgs. Lyngby, Denmark;
    366. Hayes, Daniel – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    367. Haynes, Harry – Translational Health Sciences, Department of Cellular Pathology, North Bristol NHS Trust, University of Bristol UK;
    368. Hazbei, Dan – Patologi, Blekingesjukhus, Sweden;
    369. Hazem, Bassam – Oncology and pathology, Lunds University, Sweden;
    370. He, Zhen – Department of computer science and information technology, La Trobe University, Bundoora, Victoria, Australia;
    371. Hegde, C R Akshatha – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    372. Hellyanti, Tantri – Anatomical Pathology, Cipto Mangunkusumo Hospital, Indonesia;
    373. Hendry, Shona – Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
    374. Hernandez Segura, Luis Miguel – Pathology, IMSS, Mexico;
    375. Herrmann, Markus – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    376. Hertoghs, Marjan – Pathology department of ZNA and GZA hospitals in Antwerp, Belgium;
    377. Hicham, El Attar – Biohisto Group, Annasr Pathology Center, Jedida, Morroco;
    378. Hida, Akira I. – Department of Pathology, Matsuyama Shimin Hospital, Ehime, Japan;
    379. Hiley, Crispin – Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK;
    380. Hills, Robert – Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford, UK;
    381. Hirsch, Fred R. – Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA;
    382. Hoeflmayer, Doris – Institut für Pathologie , UK Hamburg, Germany;
    383. Hollick, Morven – School of Medicine, Medical Science and Nutrition, University of Aberdeen;
    384. Horlings, Hugo M. – Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
    385. hosny, Kareem – Department of Pathology, University of Pennsylvania;
    386. Houcine, Yoldez – Department of Pathology, Salah Azeiz institute, Tunnisia;
    387. Hoyos, Valentina – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    388. Hu, Lingzhi – Sun Yat-sen University, China;
    389. Huang, Erich – National Cancer Institute, Maryland, USA;
    390. Huang, Richard – Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA;
    391. Hude?ek, Jan – Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
    392. Hurtado, Ana María – Anatomical Pathology, IMIB, Spain;
    393. Husain, Zaheed – Praava Health, Dhaka, Bangladesh;
    394. Huynh Giang, Chau – Pathology, Hung Vuong Hospital, Vietnam;
    395. Hytopoulos, Evangelos – iRhythm Technologies, California, USA;
    396. HyytiÇÏinen, Aini – Department of Oral and Maxillofacial Diseases, Helsinki, Finland;
    397. Idowu, Michael – Pathology, Virginia COmmonwealth University Health, Virgina, USA;
    398. Ignatiadis, Michail – Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium;
    399. Ilieva, Nevena – Pathology, Complex oncology center Plovdiv, Bulgaria;
    400. Indriani, Vika – Pathology Laboratory, Hermina Kemayoran Hospital, Indonesia;
    401. Inurrigarro, Gloria – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    402. Ioana Eliza, Gaianu – Department of Pathology, Emergency University Hospital, Bucharest, Romania;
    403. Irshad, Sheeba – King’s College London & Guy’s & ST Thomas’ NHS Trust;
    404. Ishida, Mitsuaki – Department of Pathology and Laboratory Medicine, Kansai Medical University, Osaka, Japan.;
    405. iturbe, julian – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    406. Iturriagagoitia, Alicia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    407. Jabbar, Khalid Abdul – Centre for Evolution and Cancer; Division of Molecular Pathology, The Institute of Cancer Research, London, UK;
    408. Jahangir, Chowdhury Arif – UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland;
    409. Jang, Danny – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    410. Jank, Paul – Department of Pathology, University of Marburg, Marburg, Germany;
    411. janssen, emiel – Department of pathology, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Technology, University of Stavanger, Stavanger, Norway
    412. Jelinic, Petar – Merck & Co., Inc., Kenilworth, USA;
    413. Ji, Juan – Pathology, Sichuan Cancer Hospital & Institute, China;
    414. Joensuu, Heikki – Helsinki University Central Hospital, Helsinki, Finland;
    415. John, Tom – Department of Medical Oncology, Austin Health, Heidelberg, Australia;
    416. Johnson, Douglas B. – Department of Medicine, Vanderbilt University Medical Centre, Nashville, USA;
    417. Johri, Ritika – Pathology, Aiims bhopal, India;
    418. Jonas, Sarah – Gustave Roussy, France;
    419. Joseph, Tessy – Pathology, Government Medical College Ernakulam, India;
    420. Juco, Jonathon W. – Merck & Co., Inc., Kenilworth, USA;
    421. kadivar, maryam – Pathology, Iran university of mefical sciences, Iran;
    422. “Kahila, Mohamed – Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA
    423. ; “
    424. Kalavar, Shyam – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    425. Kalaw, Emarene – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    426. Kallala, Amine – Hopitalle Charles Nicolle, Tunis;
    427. Kang, Jun – Pathology, The Catholic University of Korea, South Korea;
    428. Karigu, Jeniffer – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    429. Karunwi, Kezia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    430. Kataoka, Tatsuki – Department of Pathology, Iwate Medical University;
    431. Kawaguchi, junzo – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    432. Kawaguchi, Kosuke – Department of Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan;
    433. Kerner, Jennifer – PathAI Inc., Cambridge, USA;
    434. KHALED, LOUNIS – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    435. Kharidehal, Durga – Department of pathology, Narayana Medical College, Nellore, Andhra Pradesh, India;
    436. Kharmoum, Saoussan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    437. Khiroya, Reena – Department of cellular pathology, University College Hospital London, United Kingdom;
    438. Khojasteh, Mehrnoush – Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA, USA;
    439. Khramtsov, Andrey – Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA;
    440. Khramtsova, Galina – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    441. Khurram, Ali – Unit of Oral and Maxillofacial Pathology, University of Sheffield, United Kingdom;
    442. Kikawa, Yuichiro – Breast Surgery, Kansai Medical University Hospital, Osaka, Japan.;
    443. Killeen, Jeff – Kapiolani Medical Center for Women and Children, University of Hawaii Cancer Center, Honolulu, Hawaii, USA;
    444. Kim, Gun Min – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    445. Kim, Seong-Rim – National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, USA;
    446. Kimura, Yuri – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    447. King, Simon – Health, Australia;
    448. Kiraz, Umay – Department of pathology, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Technology, University of Stavanger, Stavanger, Norway
    449. Kirtani, Pawan – Histopathology,  Aakash Healthcare Superspeciality Hospital, New Delhi.;
    450. Kiruka, Edgar – Driving, Imperial Driving School, Kenya;
    451. Klaiman, Eldad – Roche;
    452. Klaushen, Frederick – Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany;
    453. Klein, Jonathan – Albert Einstein College of Medicine in New York, USA;
    454. Klein, Molly – Department of Laboratory Medicine and Pathology, University of Minnesota, USA;
    455. Kodach, Liudmila – Department of Pathology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam;
    456. Koeppen, Harmut – Research Pathology, Genentech Inc., South San Francisco, USA;
    457. Kogawa, Takahiro – Japanese Foundation for Cancer Research, Tokyo, Japan;
    458. Kok, Marleen – Divisions of Medical Oncology, Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
    459. Komforti, Miglena – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    460. Konishi, Eiichi – Departments of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.;
    461. Konstantinov, Aleksei – Department of Pathology,  Saint-Petersburg clinical scientific and practical center for specialised types of medical care (oncological), St.Petersburg, Russia.;
    462. Kooreman, Loes – Department of pathology, Maastricht University Medical Centre, Maastricht, the Netherlands;
    463. Korski, Konstanty (Popi) – Data, Analytics and Imaging, Product Development, F.Hoffmann-La Roche AG, Basel, Switzerland;
    464. Kos, Zuzana – BC Cancer Vancouver Centre; University of British Columbia, Department of Pathology and Laboratory Medicine;
    465. Koulovasilopoulos, Andreas – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    466. Kovacs, Aniko – Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    467. Kowacs, Vlad – Oncological Dispancer, LMU, Ukraine;
    468. Kozuka, Yuji – Department of Pathology, Mie University School of Medicine, Mie, Japan;
    469. Krause, Daniel – Department of Pathology, KSGR, Switzerland;
    470. Krishnan, Aswathi – Pathology, Malabar cancer centre, India;
    471. Kucuk, Gultekin Ozan – General Surgery, University of Health Sciences, Samsun training and Research Hospital, Turkey;
    472. Kulka, Janina – Department of Pathology, Semmelweis University, Budapest, Hungary;
    473. Kumar, George – Bristol Myers Squibb;
    474. Kuo, Fu-Shan – Nimbus, USA;
    475. Kuo, Fu-Shan – Bioinformatics, Brandeis U, USA;
    476. Kurebayashi, Yutaka – Department of Pathology, Keio University School of Medicine, Tokyo, Japan.;
    477. Kurkure, Uday – Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA, USA;
    478. KURUKAFA, DİĞDEM – Department of Pathology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Turkey;
    479. Kwon, Sun Young – Pathology, Keimyung University Dongsan Hospital, South Korea;
    480. Kwon, Tony – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    481. Labanca, Maria Jose – Hospital Italiano de Buenos Aires, Argentina;
    482. LABORIE, Vincent – Pathology, AMAPATH;
    483. Lacroix-Triki, Magali – Department of Pathology, Gustave Roussy, Villejuif, France;
    484. Laenkholm, Anne-Vibeke – Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark; Department of Surgical Pathology, University of Copenhagen, Copenhagen, Denmark
    485. Lai QJ, Jeff – Anatomical Pathology, Sarawak General Hospital, Malaysia;
    486. Lakhani, Sunil R. – The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia;
    487. Lambertini, Matteo – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    488. Landini, Paola – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    489. Lang-Schwarz, Corinna – Institute of pathology, Klinikum Bayreuth GmbH, Friedrich-Alexander-University Erlangen-Nuremberg, Bayreuth, Germany;
    490. Larsimont, Denis – Department of Pathology, Jules Bordet Institute, Brussels, Belgium;
    491. lashkarizadeh, mahdiyeh – Pathology, Department of Pathology and Stem Cell Research Center, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran;
    492. Lasiter, Laura – Friends of Cancer Research;
    493. Laudus, Nele – Biomedical Quality Assurance Research Unit, KU Leuven, Leuven, Belgium;
    494. Layman, Wanda – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    495. Lazar, Alexander J. – Departments of Pathology, Genomic Medicine, Dermatology, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
    496. LÇüpez, Beatriz – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    497. Le Quesne, John – Leicester Cancer Research Centre, University of Leicester, Leicester, and MRC Toxicology Unit, University of Cambridge, UK;
    498. Leavitt, Matt – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    499. Ledford, Heidi – Nature;
    500. Lee, Yury – Department of Pathology, Pusan National University Hospital, South Korea;
    501. Lefevre, Alex – Roche Diagnostics, Belgium;
    502. leion, felicia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    503. Lemonnier, Jerome – R&D UNICANCER, Paris, France;
    504. Lennerz, Jochen K. – Center for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA;
    505. Leon-Ferre, Roberto – Department of Oncology, Mayo Clinic, Rochester, USA;
    506. Lerousseau, Marvin – Centre for Computational Biology (CBIO), Mines Paris, PSL University, 75006 Paris, France; Institut Curie, PSL University, 75005 Paris, France
    507. Leung, Sam – University of British Columbia, Vancouver, British Columbia, Canada;
    508. Li, Lingyu – School of Control Science and Engineering, Shandong University, China;
    509. Li, Ruiyu – Department of Pathology, PUMCH, China;
    510. Li, Xiaoxian (Bill) – Department of Pathology and Laboratory Medicine, Emory University, USA;
    511. Li, Yuan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    512. Li, Zaibo – Department of Pathology, Wexner Medical Center at the Ohio State University, Ohio, USA;
    513. Liang, Peir-In – Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan;
    514. Liao, Linda – Diagnostic Development, Ontario Institute For Cancer Research, Canada;
    515. Lien, Huang-Chun – Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan;
    516. Liepniece- Karele, Inta – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    517. Lin, Yuchun – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    518. Linderholm, Barbro – Department of Oncology/Pathology, Karolinska Insitutet, Sweden;
    519. Linn, Sabine – Netherlands Cancer Institute, The Netherlands;
    520. LIU, DONGYAN – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    521. “Liu, Minetta – Mayo Clinic, Rochester, Minnesota Joint Appointment, Department of laboratory Medicine and Pathology
    522. Research Chair, Division of Medical Oncology
    523. ; “
    524. Liu, Steve – Pathology, Washington University at St. Louis;
    525. Liu, Shi-Wei – Sichuan Cancer Hospital, Chengdu, China;
    526. Lo, Amy – Research Pathology, Genentech Inc., South San Francisco, USA;
    527. Loménie, Nicolas – Université Paris Cité, France;
    528. Lopac, Danijel – Clinic for orthopedic surgery Lovran, Croatia;
    529. lopes de brito, mayana – Medical Oncology, Clínica AMO, Brazil;
    530. Lopez, Patricia – Pathology, Instituto Nacional de Cancerologia, Colombia;
    531. Lowe, Amanda – Visiopharm;
    532. Lu, Fang-I – Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
    533. Luen, Stephen J. – Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia;
    534. Luff, Ronald – Anatomic Pathology for Clinical Trials, Quest Diagnostics, USA;
    535. Lunardi, Maria – ULSS1 Dolomiti, Italy;
    536. Lundin, Johan – Institute for Molecular Medicine Finland, University of Helsinki; Department of Global Public Health, Karolinska Institutet, Stockholm
    537. Luu, Tung – Department of Pathology, University of Medicine and Pharmacity, Vietnam;
    538. Luz, Paulo – Medical Oncology, Centro Hospitalar Universitario do Algarve, Faro, Portugal;
    539. Ly, Amy – Department of Pathology, Massachusetts General Hospital, Boston, MA, USA;
    540. Madabhushi, Anant – Department of Biomedical Engineering, Radiology and Imaging Sciences, Biomedical Informatics, Pathology, Georgia Institute of Technology and Emory University, USA;
    541. Madrid, Manuelito – St. Luke’s Medical Center, Philippines;
    542. Maeso, M Carmen – Pathology, Hospital La Candelaria, Spain;
    543. Maetens, Marion – Katholieke Universiteit Leuven, Belgium;
    544. Mahon, Sarah – Department of Patholgy, Mater Misericordiae University Hospital;
    545. Mahsob, Marina – I am enthusiastic, self-motivated, hard working and responsible person;
    546. Maia, Maiko – Department of Pathology, FCECON, Brazil;
    547. Maita, Richard – Anatomical Pathology, Essalud, Peru;
    548. Majjaj, Samira – Institut Jules Bordet, Belgium;
    549. Makanga, Alexander – Histopathology Department, Betsi Cadwaladr University Health Board, United Kingdom;
    550. Makar, Rosemary – Kinght Cancer Institute, Oregon Health & Sciences University, Portland, Oregon;
    551. Makitie, Antti – Department of Otorhinolaryngology – Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
    552. Maley, Sai – NRG Oncology/NSABP Foundation, Pittsburgh, USA;
    553. Maley, Sai – NSABP, USA;
    554. malhaire, caroline – Radiology, Institut Curie, France;
    555. Malhotra, Mridul – Medical Oncology, Asian Institute of Medical Sciences, India;
    556. Malushkova, Maria – MNIOI im Gercena, Russia;
    557. Mandelkow, Tim – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    558. Manur Narasimhamurthy, Vidya – Manipal Hospitals, Bangalore;
    559. Marabi, Monalyn – Department of Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong;
    560. Marchio, Caterina – University of Turin at Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;
    561. Marks, Douglas K. – Perlmutter Cancer Center, NYU Langone Health, USA;
    562. “Martel, Anne – Medical Biophysics, University of Toronto, Toronto, Canada; Imaging Research, Sunnybrook Research Institute, Toronto, Canada
    563. “
    564. Marti, Merce – Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, Spain;
    565. “Martin, Miguel – Professor of Medicine, Head, Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain
    566. ; “
    567. Martinez Celorrio, Mariano – Luzán 5, Spain;
    568. Martínez Vazquez, Paula – Ginecology, Hospital Magdalena V de Martínez, Gral Pacheco Tigre, Argentina;
    569. Martyn, Cian – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    570. Martyn, CIan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    571. Mathieu, Marie-Christine – Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France;
    572. Mathur, Dhanvi – Life Sciences, Ahmedabad University, Gujarat, India;
    573. Matsumoto, Hirofumi – Department of Pathology, Nakagami Hospital, Okinawa, Japan;
    574. McArthur, Heather – Clinical Director of Breast Cancer Grant and Komen Distinguished Chair in Clinical Breast Cancer Research, UTSW, Dallas, Tx, USA;
    575. McDonald, Elizabeth – Breast Cancer Translational Research Group , University of Pennsylvania, USA;
    576. McKenzie, Hayley – Medical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom;
    577. McLaren, Bernadette – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    578. McShane, Lisa – Cancer Therapy Evaluation Program, National Cancer Institute, Maryland, USA;
    579. mego ramirez, fiorela – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    580. Mehrotra, Ravi – Indian Cancer Genomic Atlas, India; Centre for Health, Innovation and Policy Foundation, India
    581. Mendes, Larissa – Oncology Department, Cancer Institute,  University College London, London, United Kingdom;
    582. Merard, Reena – Anatomic Pathology, Q2 Lab Solutions, USA;
    583. Mercurio, Paola – School of Electrical, Mechanical and Infrastructure Engineering, University of Melbourne, Melbourne VIC 3010, Australia; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia
    584. MIELE, RAFFAELE – ASL Napoli 1 Centro, Ospedale Pellegrini, Italy;
    585. Miglietta, Federica – Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy;
    586. migliora, paola – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    587. Millar, Ewan – NSW Health Pathology, St George Hospital, Sydney, Australia;
    588. Miller, Iain – Pathology, Stanford Health Care, USA;
    589. Millward, Joshua – Department of computer science and information technology, La Trobe University, Bundoora, Victoria, Australia;
    590. Minhas, Fayyaz – Tissue Image Analytics Centre, Warwick Cancer Research Centre, PathLAKE consortium, Department of Computer Science, University of Warwick, Coventry, United Kingdom;
    591. Minhofer, Nora – Forschung, Institut für Pathologie, Germany;
    592. Mishra, Ranu – Department of Pathology, NSCB Medical College, india;
    593. Misialek, Michael – Vernon Cancer Center, Newton-Wellesley Hospital, Newton, USA.;
    594. Mittal, Shachi – Deaprtment of Chemical Engineering and of Laboratory Medicine and Pathology, University of Washington, Seattle, USA;
    595. Mittendorf, Elizabeth – Dana-Farber / Harvard Cancer Center, Massachussets, USA;
    596. Modesto Araujo e Porfirio, Monica – Department of Pathology, Argos – Fortaleza-CE, Brazil;
    597. Mohan, Raj – Command Hospital;
    598. Mok, Lydia – BME, UCSC, USA;
    599. Molero, Aida – Pathology, Hospital General de Segovia, Spain;
    600. Molinero, Luciana – Oncology Biomarker Development, Genentech-Roche;
    601. Molteni, Luisa Paola – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    602. Mommens, Rudi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    603. Mon, Nan Cho Nwe – Department of Medical Research, Ministry of Health, Myanmar;
    604. Montagna, Giacomo – Breast surgery, Memorial Sloan Kettering Cancer Center, Boston, MA, USA;
    605. Monteiro, Joao – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    606. Moore, David A. – CRUK Lung Cancer Centre of Excellence, UCL and Cellular Pathology Department, UCLH, London;
    607. Moreira, Andre – Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University, New York, New York, USA;
    608. Moriya, Takuya – Department of Pathology, Kawasaki Medical School, Okayama, Japan;
    609. Mosto, Julian – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    610. Mukohara, Toru – National Cancer Center Hospital, Tokyo, Japan;
    611. Mukolwe, EDWIN – Driving, Kykaan, Kenya;
    612. Mundim, Fiorita – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    613. Mura, Giovanni – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    614. Murguai, Mario – Department of Anatomical Pathology, UMAE Hospital de Especialidades N ° 1, Guanajuato, Mexico;
    615. Murthy, Sudha – Datar Cancer Genetics India, Nasik, India;
    616. Mushtaq, Shamim – Department of Biochemistry, Ziauddin University, Karachi Pakistan;
    617. Mutter, Robert – Radiation Oncology, Mayo Clinic, Rochester, Minnesota;
    618. Naber, Stephen – Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, USA;
    619. Naidoo, Nish – Cancer and Pharmacological Studies, King’s College Hospital and King’s College London, United Kingdom;
    620. Nandra, Nanrita – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    621. Naury, Briceño – Pathology, Incart, Dominican Republic;
    622. NAYLER, Simon – Department of Pathology, Gritzman and Thatcher Inc, South Africa;
    623. Nederlof, Iris – Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
    624. Nelson, Brad H. – Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, Canada;
    625. Nesbeth, Yolanda – BMS;
    626. Nibali, Aiden – Department of computer science and information technology, La Trobe University, Bundoora, Victoria, Australia;
    627. Nielsen, Tyler – Oncocyte, Nashville, USA;
    628. Nighat, Hussain – Pathology and Laboratory Medicine, AIIMS, Raipur, India.;
    629. Nogami, Mako – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    630. Norton, Larry – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    631. Nott, Louise – Oncology, Icon Cancer Centre Hobart, Australia;
    632. Nuciforo, Paolo – Molecular Oncology Group, Vall d’Hebron Institute of Oncology, Barcelona, Spain;
    633. Nurkhairul Bariyah, Baharun – Department of Pathology, The National University of Malaysia, Malaysia;
    634. O’Toole, Sandra – The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Australian Clinical Labs, Australia;
    635. Ofra, Filipp – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    636. Okamoto, Takeru – Chugai Pharmaceutical Co., Ltd;
    637. Okamoto, Tsuyoshi – Kyowa Kirin Co., Ltd;
    638. Olofsson, Helena – Department of Clinical Pathology, Akademiska University Hospital, Uppsala, Sweden;
    639. O’Loughlin, Mark – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    640. Oner, Gizem – Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital;
    641. Onguru, Onder – Pathology, ASM, Turkey;
    642. Onurb, Skuf – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    643. Onyuma, Timothy – Pathology, Kenyatta National Hospital, Kenya;
    644. Onyuma, Timothy – Kenyatta National Hospital in Nairobi, Kenya.;
    645. Ortega, maria – Pathology, DIAGNOSTICOSRL, Uruguay;
    646. Orvieto, Enrico – UOC Anatomia Patologica, ULSS5 Polesana Rovigo, Italy;
    647. Özcan, Demet – Pathology, Aarhus University Hospital, Denmark;
    648. Ozgur, Elif – Department of Pathology, Ankara University, Turkey;
    649. Özkan, Atakan – Biomedical Engineering, Istanbul Technical University, Turkey;
    650. Ozturk, Tulin – Pathology, Istanbul University-Cerrahpasa, Medical School, Turkey;
    651. Pacifico, Jana Priscila – Dasa Oncologia, Brazil;
    652. Page, David B. – Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA;
    653. Paik, Soonmyung – National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania, USA;
    654. palfreeman, simon – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    655. palma, fabio – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    656. Papathomas, Thomas – Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Pathology, Drammen Sykehus, Vestre Viken HF, Drammen, Norway
    657. Park, Susan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    658. Parker, Charles – UCL Cancer Institute;
    659. Parrilla Castellar, Edgardo – Q2 Solutions;
    660. Parrodi, Jeannette – Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia;
    661. PARVIN, RAZIA – Pharmacy, University of Asia Pacific, Bangladesh;
    662. pascale, lucht-versini – Pathology, Hospital Eugenie, France;
    663. PASUPATHY, ASOKAN – Department of Pathology, NSW Health Pathology, NSW Australia;
    664. Patil, Asawari – Pathology, Tata Memorial Hospital, ACTREC, India;
    665. Patnayak, Rashmi – Pathology, Hi-Tech Medical College and hospital, India;
    666. Pavcovich, Marta – Pathology, Complejo hospitalario universitario insular materno infantil, Spain;
    667. Pavon, Ida – Ulss 3, Italy;
    668. Peale, Franklin – Oncology Biomarker Development, Genentech-Roche;
    669. Peeters, Dieter – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    670. Peeters, Dieter – HistoGeneX NV, Antwerp, Belgium and AZ Sint-Maarten Hospital, Mechelen, Belgium;
    671. Penault-Llorca, Frederique – Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000 Clermont Ferrand, France;
    672. Penazova, Marketa – Pathology, Hospital Nove Mesto na Morave, Czech Republic;
    673. Perera, Rashindrie – University of Melbourne, Parkville, Australia;
    674. Perez, Edith – Department of Oncology, Mayo Clinic, Rochester, USA;
    675. Perez, Sarah – Pathology, Christus Muguerza Alta especialidad, Mexico;
    676. periasamy, shanthi – Anatomical Pathology, John Hunter Hospital, Australia;
    677. Petit, Anna – Institute of Oncologia, Barcelona, Spain;
    678. Philip, Febby K – Pathology, Government medical College Ernakulam, Kerala India;
    679. Philip, Reena – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    680. Piccart, Martine – Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium;
    681. PICOT, Remi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    682. Pierce, Robert H. – Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, USA;
    683. Pimenta, Isabela – Pathology, Imagepat, Brazil;
    684. Pinard, Christopher – Radiogenomics Laboratory, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Canada
    685. Pinto Cardenas, Juan Carlos – Diagnostico de Salud Animal SA, CDMX, Mexico;
    686. Pistilli, Barbara – Gustave Roussy, France;
    687. Platt, James – Leeds Institute of Medical Research, University of Leeds, United Kingdom;
    688. Pogue-Geile, Katherine – NSABP/NRG Oncology, Pittsburgh, PA, USA;
    689. Poortmans, Philip – Department of Radiation Oncology, Iridium Kankernetwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp 2610, Belgium.;
    690. Porcellato, Ilaria – Department of Veterinary Medicine, University of Perugia, Italy;
    691. Posso, Veronica – Pathology, HECAM, Ecuador;
    692. Preda, Ovidiu – Surgical Pathology, San Cecilio Hospital, Granada, Spain;
    693. Preda, Ricardo – Anatomical Pathology, NSW Health, Australia;
    694. Preusser, Matthias – Department of Medicine, Clinical Division of Oncology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria;
    695. Prieto Potin, Ivan – Fundación Jiménez diaz, Spain;
    696. Provenzano, Elena – Department of histopathology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK; Cambridge NIH Biomedical Research Centre, Cambridge, UK
    697. Pruitt, Scott – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    698. Qing, Guo – Department of Pathology, Wuxi People’s Hospital, China;
    699. Quinn, Cecily – Department of Pathology, St Vincent’s University Hospital and University College Dublin, Dublin, Ireland;
    700. Quintana, Angela – Vall d’Hebrón Hospital Research Institute, Autoimmune Diseases department, Barcelona, Spain;
    701. Quintella, Danielle – Pathology, UFRJ, Brazil;
    702. Quynh, Bui – University of Medicine & Pharmacy HCMC (UMP), Vietnam;
    703. Radosevic-Robin, Nina – Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France;
    704. Radovich, Milan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    705. Raghunadha Rao, Digumarti – KIMS ICON Hospital, Vishakapatnam, India;
    706. Rahbari, Mohammad – Division of Chronic Inflammation and Cancer, German Cancer Research Center, Germany;
    707. Rahman, Arman – UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland;
    708. Rajpoot, Nasir – University of Warwick, United Kingdom;
    709. Rakauskiene, Virginija – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    710. ramieri, maria teresa – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    711. ramirez, ana – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    712. Ramirez Ruz, Jose – Pathology, Hospital Clinic Barcelona, Spain;
    713. Ramsaroop, Reena – Surgical Pathologist, North Shore Hospital, WDHB, Auckland, New Zealand;
    714. Rapoport, Bernardo L – The Medical Oncology Centre of Rosebank, 129 Oxford Road, Saxonwold 2196, Johannesburg, South Africa; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
    715. rassam, loui – Laverty, Australia;
    716. Rau, Tilman T. – Institute of Pathology, University Hospital Düsseldorf and Heinrich-Heine-University Düsseldorf, Germany;
    717. Raymond, Wendy – Dept Surgical Pathology; FLINDERS MEDICAL CENTRE, Bedford Park and CLINPATH PATHOLOGY; ADELAIDE, AUSTRALIA;
    718. Rebelatto, Marlon C. – Translational Sciences, MedImmune, Gaithersberg, USA;
    719. Rediti, Mattia – Institut Jules Bordet, Belgium;
    720. Regan, Meredith M. – Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA;
    721. Regitnig, Peter – Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria;
    722. Reisenbichler, Emily – Department of Pathology, Yale School of Medicine, New Haven, USA;
    723. Reis-Filho, Jorge – Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA;
    724. Rexhepaj, Elton – Research & Development, Sanofi;
    725. REYES DE LA GARZA, ITZEL – Pathology, VERAPATH, Mexico;
    726. Riaz, Nazia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    727. Ribeiro, Joana – Gustave Roussy, Département de médecine oncologique, F-94805, VILLEJUIF France;
    728. richardet, eduardo – Instituto Oncológico Córdoba, Spain;
    729. Richardson, Andrea – Department of Pathology, Johns Hopkins Hospital, Baltimore, USA;
    730. Roberts, Mustimbo – BMS;
    731. Roblin, Elvire – Université Paris-Saclay, Univ. Paris-Sud, Villejuif, France; and Service de biostatistique et d’épidémiologie, Gustave Roussy, Villejuif, France;
    732. Robson, Mark – Memorial Sloan Kettering Cancer Center, NY, US;
    733. rodriguez, laura – Pathology, Higa, Argentina;
    734. Rogerinho, Francisco Rogerio – LNRCC-LIGA, Brazil;
    735. ROIG I QUILIS, IGNASI – Departmento de Anatomia Patologica, Hospital de Terrassa, Barcelona, Spain;
    736. Rojo, Federico – Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain;
    737. Rojo-Sebastian, Alejandro – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    738. Rojpornpradit, Prayuth – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    739. Romero, Diana – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    740. Roslind, Anne – Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark;
    741. Rossetti, Claudia – Anatomical Pathology, Faculdade de Medicina do ABC, Brazil;
    742. Rothe, Francoise – Institut Jules Bordet, Belgium;
    743. Rotsaert, Catherine – Institut Jules Bordet, Belgium;
    744. Roxanis, Ioannis – Institute of Cancer Research;
    745. Ruiz, Diana – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    746. Ryan, Lucy – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    747. Sabanathan, Dhanusha – Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia;
    748. Sabino, Dora – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    749. Sadeghi, Saed – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    750. Saeger, Kai – Vm Scope, Germany;
    751. Saghatchian, Mahasti – Pathology, Institute Gustave Roussy, France;
    752. Sahay, Ayushi – Pathology, Tata Memorial Centre, Mumbai, India;
    753. Saito, Noriyuki – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    754. Saji, Shigehira – Medical Oncology, Fukushima Medical University Hospital, Japan;
    755. Sakatani, Takashi – Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan;
    756. Salido, eduardo – Pathology, Hospital Universitario de Canarias, Tenerife, Spain;
    757. Salomon, Anne-Vincent – Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France;
    758. Salto-Tellez, Manuel – Integrated Pathology Unit, the Institute of Cancer Research, London, UK; Precision Medicine Centre, Queen’s University Belfast, belfast, UK
    759. Saltz, Joel – Department of Biomedical Informatics and Department of Pathology, Stony Brook School of Medicine, Stony Brook, Usa;
    760. Samberg, Nancy – Executive Director, Medical Affairs, Iovance Biotherapeutics, USA;
    761. Sanchez, Joselyn – Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru;
    762. Sanders, Melinda E. – Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Centre, Nashville, USA;
    763. Sandstrom, Josefine – Linköping University;
    764. Sane, Komal – Global Development, Regeneron Pharmaceuticals, USA;
    765. Sant, Sneha – Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia;
    766. Santos, Damilys Joelly – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    767. Sapino, Anna – University of Turin / Candiolo Cancer Institute – FPO, IRCCS, Candiolo, Italy;
    768. Sarancone, Sandra – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    769. Sasikala, Krishnamurthy – Department of Pathology, SSIMS & RC, Davanagere, India;
    770. Sater, Houssein – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    771. saurine, tricia – Anatomical pathology, Royal North Shore Hospital;
    772. Savas, Peter – Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, VIC, Australia
    773. Saxon, Sarah – Anatomical Pathology, Royal Adelaide Hospital, Australia;
    774. Sayed, Shahin – Pathology, Aga Khan University Hospital, Nairobi, Kenya;
    775. SAYIR, Seda Nur – Department of Pathology, Ankara University faculty of Medicine, Turkey;
    776. Schelfhout, Vera – Department of Pathology, AZ Sint-Maarten, Belgium;
    777. Schmitt, Fernando – Department of Pathology, Medical Faculty of Porto University, Porto, Portugal.;
    778. Schneck, Mary – Histogenex;
    779. Schnitt, Stuart – Department of Pathology, Brigham and Women’s Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA, USA;
    780. Schreiber, Heide – Pathology, institut arnaboldi, Switzerland;
    781. Schreurs, Arthur – Public Health and Primary Care, Katholieke Universiteit Leuven;
    782. Schwaegerle, Sonya – Akoya Biosciences, USA;
    783. “Scott, Ely – Translational Pathology,
    784. Translational Sciences and Diagnostics/Translational Medicine/R&D, Bristol Myers Squibb, Princeton, NJ; “
    785. Scott, Loren – Ontario Institute for Cancer Research, Toronto, Canada;
    786. Sebastian, Manu – Departments of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
    787. Sedarat, Franklin – Q2 Solutions;
    788. SEDKI, Mohammed – Essone, Paris-Saclay university, France;
    789. Seethataman, Radha – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    790. Senkus-Konefka, Elżbieta – Department of Oncology & Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland;
    791. Shah, Aekta – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    792. shahid, Moazzam – Research, Ziauddin University, Pakistan;
    793. Sharma, Ashish – Department of Biomedical Informatics, Emory University, GA, USA;
    794. Sharma, Priyanka – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    795. Sharma, Vijay – Pathology, Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Trust, United Kingdom;
    796. Shash, Emad – Breast Cancer Comprehensive Center, National Cancer Institute, Cairo University, Cairo, Egypt;
    797. Shear, Jeffrey – Information Technology, Wiss & Company, LLP, J Shear Consulting, LLC, New York, USA;
    798. Shi, Leming – Center for Pharmacogenomics and Fudan-Zhangjiang, Center for Clinical Genomics School of Life Sciences and Shanghai Cancer Center, Fudan University, China;
    799. Shibata, Nobuhiro – Breast Surgery, Kansai Medical University Hospital, Osaka, Japan.;
    800. Shimoi, Tatsunori – National Cancer Center Hospital, Tokyo, Japan;
    801. Shmidt, Alla – Policlinic, The center of oncology and nuclear medicine, Russia;
    802. Shu, Yazaki – National Cancer Center Hospital, Tokyo, Japan;
    803. Shui, Ruohong – Department of Pathology, Fudan University Cancer Center, China;
    804. Sigurd, Lax – Department of Pathology, Hospital Graz II, Academic Teaching Hospital of the Medical University Graz, Austria;
    805. Silva, Abraham – Pathology, Roche, Germany;
    806. Singh, Ashok – Pathology, AIIMS Rishikesh, India;
    807. Singh, Baljit – Department of Pathology, New York University Langone Medical Centre, New York, USA;
    808. Singh, Rajendra – Icahn School of Medicine at Mt. Sinai, New York, NY, USA;
    809. Sirtaine, Nicolas – Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium;
    810. Sitic, Sanda – Department of Oncological Pathology and Clinical Cytology, Clinic for Tumors, Croatia;
    811. Siziopikou, Kalliopi P. – Department of Pathology, Section of Breast Pathology, Northwestern University Feinberg School of Medicine, Chicago IL, USA;
    812. Smailys, Gediminas – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    813. Smart, Chanel – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    814. Sofopoulos, Michail – Department of Surgical Pathology, “Saint Savvas” Regional Anticancer Hospital, Athens Greece;
    815. Søiland, Håvard – Pathology, Stavanger University Hospital, Norway;
    816. SOLER, TERESA – Department of Pathology, University Hospital of Bellvitge, Oncobell, IDIBELL, L’Hospitalet del Llobregat, Barcelona 08908, Catalonia, Spain;
    817. Solinas, Cinzia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    818. Solinas, Cinzia – Azienda AUSL, Regional Hospital of Aosta, Aosta, Italy;
    819. Solomon, Benjamin – Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia;
    820. Solorzano Rendon, Jose Luis – Pathology and Molecular Diagnostics department, MD Anderson Cancer Center Madrid, Spain;
    821. “Somaiah, Navita – Translational Breast Radiobiology, Institute of Cancer Research
    822. Honorary Consultant Clinical Oncologist (Breast), The Royal Marsden
    823. ; “
    824. Soni, Rashida – Pathology, Q2 lab solutions and Henry Mayo Newhall Hospital, USA;
    825. Sooriyaarachchi, Shyamini – Histopathology, Faculty of Medicine Colombo, Sri Lanka;
    826. SOUTO MAIOR, MARCELO – Pathology, Federal University of Pernambuco, Brazil;
    827. Souza, Maiara – Pathology, Imagepat, Brazil;
    828. Souza, Sandra – Oncology Merck & Co, New Jersey, USA;
    829. Sparano, Joseph – Department of Medicine, Department of Obstetrics & Gynecology and Women’s Health, Albert Einstein Medical Center, Bronx, USA;
    830. Specht Stovgaard, Elisabeth Ida – Department of Pathology, Herlev and Gentofte University Hospital, Herlev, Denmark;
    831. Spencer, Charlotte – CRICK, United Kingdom;
    832. Spengler, Eunice – Departmento de Patologia, Hospital Universitario Austral, Argentina.;
    833. Srinivas, Somalvar – Department of Pathology, All India Institute of Medical Sciences, Hyderabad, India;
    834. Srinivasan, Ashok – Chief Scientific Officer, Autism Impact Fund, USA;
    835. Stanciu Pop, Claudia – Pathology, CHU UCL NAMUR;
    836. Starac, Diana – Anatomical Pathology, Australian Clinical Labs, Australia;
    837. Steele, Keith E. – Translational Sciences, MedImmune, Gaithersberg, USA;
    838. Steenbruggen, Tessa – Medical Oncology, The Netherland Cancer Institute, The Netherlands;
    839. Stenzinger, Albrecht – Institute of Pathology, University Hospital Heidelberg, Germany; Centers for Personalized Medicine (ZPM), Heidelberg, Germany
    840. Stover, Daniel – Ohio State University Comprehensive Cancer Center, Ohio, USA;
    841. Sua, Luz – Department of Pathology, Fundación Valle del Lili, Cali, Colombia;
    842. Subramaniam, Manish Mani – Anatomic Pathology, Q2 Lab Solutions, United Kingdom;
    843. subramanian, karthickbalan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    844. Suciu, Cristian – Morphologic Microscopy, University of Medicine and Pharmacy Victor Babes Timisoara, Romania;
    845. Sughayer, Maher – Department of Pathology, King Hussein Cancer Center, Jordan;
    846. Sugie, Tomohagu – Department of Surgery, Kansai Medical School, Hirakata, Japan;
    847. Sugie, Tomoharu – Breast Surgery, Kansai Medical University Hospital, Osaka, Japan.;
    848. Sur, Daniel – Department of Medical Oncology, University of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca, Romania;
    849. Susheela, Kondandapani – Department of Pathology, Indo-American Hospital, Hyderabad;
    850. Suwan, Kris – Institute of Pathology, Ministry of Public Health, Thailand;
    851. Suwan, Kritpricetag – Anatomical Pathology, Insitute of Pathology,, Thailand;
    852. Suzuki, Eiji – Kyoto University, Department of Breast Surgery, Kyoto, Japan.;
    853. Swain, Sandra – Georgetown University Medical Center, Washington DC, USA;
    854. Swanton, Charles – Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK;
    855. Szpor, Joanna – Pathology, Katedra Patomorfologii UJ CM, Poland;
    856. Tabbarah, Sami – Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;
    857. Tageldin, Mohamed Amgad – Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA;
    858. Takada, Masahiro – Kyoto University, Department of Breast Surgery, Kyoto, Japan.;
    859. Tan, Benjamin – Anatomical Pathology, Singapore General Hospital, Singapore;
    860. Tanaka, Sunao – Kyoto University, Kyoto, Japan;
    861. Tang, Kenneth – NSWHP Gosford AP, NSW Health Pathology, Australia;
    862. Taxter, Timothy – Tempus, Inc, USA;
    863. Tecic Vuger, Ana – Breast Cancer Department, University Hospital for Tumors, Croatia;
    864. Tejpar, Sabine – Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium;
    865. Tenorio, Sofia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    866. Teoran, Samy Stefan – Pathology, SCJUPBT;
    867. Ternes, Nils – Service de Biostatistique et d’Epidémiologie, Gustave Roussy, CESP, Université-Paris Sud, Université Paris-Saclay, Villejuif, France;
    868. Teuwen, Jonas – AI for Oncology Lab, the Netherlands Cancer Institute, Amsterdam, the Netherlands;
    869. Thagaard, Jeppe – Technical University of Denmark, Kgs. Lyngby, Denmark; Visiopharm A/S, Hørsholm, Denmark
    870. Thapa, Bibhusal – Department of Medicine, University of Melbourne, Parkville, Australia;
    871. Thia, Kevin – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    872. Thiel, Angela – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    873. Thomas, Jeremy – Q2 Solutions;
    874. Thompson, Alastair – Surgical Oncology, Baylor College of Medicine, Texas, USA;
    875. Thompson, E. Aubrey – Department of Cancer Biology, Mayo Clinic, Jacksonville, USA;
    876. tille, jean-christophe – Department of Pathology, University Hospital, Geneva, Switzerland;
    877. Timmermans, Mieke – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    878. Tiu, Crescens – Cell Death & Immunity Lab, Institute of Cancer Research, United Kingdom;
    879. TOGORES, PILAR – Medical Oncology, CENTRO ONCOLOGICO DE GALICIA, Spain;
    880. Toi, Masakazu – Department of Breast Surgery, Kyoto University, Kyoto, Japan.;
    881. Tolaney, Sara – Harvard, USA;
    882. Tong, Weida – Division of Bioinformatics and Biostatistics, U.S. Food and Drug Administration, USA;
    883. Torres, Wilhermo – Pathology, Diagnose, Brazil;
    884. Tortora, Giampaolo – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    885. Tramm, Trine – Dept. of Pathology, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark
    886. Tran, William – Department of Radiation Oncology, University of Toronto and Sunnybrook Health Sciences Centre;
    887. Trongpisutsak, Ananya – Pathology, Chulalongkorn, Thailand;
    888. Tsvetkova, Vassilena – Pathology, University of Verona, Italy;
    889. Tucker, Paul – Histopathology, Hobart Pathology, Australia;
    890. Tuhid, md.jakaria – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    891. Tung, Nadine – Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, USA;
    892. Turan, Gupse – Department of Pathology, Kocaeli University, Turkey;
    893. Turner, Sophia – Patient advocate;
    894. Turovskaya, Natalie – Central clinical hospitalm Russia;
    895. Tutt, Andrew – Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK;
    896. Uchihashi, Kazuyoshi – Surgical Pathology, NHO Saga Hospital, Japan;
    897. Urezkova, Mariia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    898. V C, Pranjali – Depatment of Pathology, Sri Shankara Cancer Hospital and Research Center, India;
    899. V Gowda, Veeksha – Depatment of Pathology, Sri Shankara Cancer Hospital and Research Center, India;
    900. Vaid, Pooja – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    901. Valdivia, Tania – Anatomical Pathology, Essalud, Peru;
    902. VALENTI, CARLA – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    903. Valerie, PASCAL – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    904. Van Bockstal, Mieke – Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.;
    905. van de Vijver, Koen K. – Department of Pathology, University Hospital Ghent, Belgium;
    906. van de Vijver, Mark – Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands;
    907. van den Berg, Jose – Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
    908. Van den Broek, Sophie – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    909. Van den Eynden, Gert – Department of Pathology, GZA-ZNA Ziekenhuizen, Wilrijk, Belgium;
    910. van der Laak, Jeroen – Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands;
    911. van Deurzen, Carolien – Department of Pathology, Erasmus MC, Cancer Institute, Rotterdam, The Netherlands;
    912. Van Diest, Paul J – Department of Pathology, University Medical Center Utrecht, The Netherlands; Johns Hopkins Oncology Center, Baltimore, MD, USA
    913. Van Hoorick, Diane – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    914. Van Loo, Sharon – PA of Charles Swanton;
    915. van Seijen, Maartje – Department of molecular pathology, Netherlands Cancer Institute, Amsterdam, Netherlands;
    916. Vazquez, Melisa – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    917. Velasco, Montse – Department of Oncology, Hospital de Mataro, Bercelona, Spain;
    918. Venet, David – Institut Jules Bordet, Belgium;
    919. Verbandt, Sara – Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium;
    920. Verghese, Gregory E. – Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK; The Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
    921. Vermeulen, Peter – Medical Oncology, GZA, Antwerp, Belgium;
    922. Vethencourt, Andrea – Institute of Oncologia, Barcelona, Spain;
    923. Vicioso, Luis – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    924. Vieth, Michael – Institute of pathology, Klinikum Bayreuth GmbH, Friedrich-Alexander-University Erlangen-Nuremberg, Bayreuth, Germany;
    925. Villena, Nadia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    926. Vincent, Delphine – Institut Jules Bordet, Belgium;
    927. Vingiani, Andrea – Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy;
    928. Vivo Serrano, Victor – Department of Pathology, Hospital General Universitario de Castello, Spain;
    929. Vlada, Nikitina – Pathology, Krasnoyarsk State MEDICAL UNIVERSITY;
    930. Voorwerk, Leonie – Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
    931. Vranic, Semir – College of Medicine, Qatar University, Qatar;
    932. Wahab, Noorul – Tissue Image Analytics Centre, Department of Computer Science, University of Warwick, Coventry, CV4 7AL, United Kingdom;
    933. Waldenback, Pia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    934. Wall, Isobelle – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    935. Walter, Thomas – Centre for Computational Biology (CBIO), Mines Paris, PSL University, 75006 Paris, France; Institut Curie, PSL University, 75005 Paris, France
    936. Wang, Yihong – Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center, Providence, USA;
    937. Warburton, Emily – Cancer Institute, UCL, United Kingdom;
    938. Watkins, Tom – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    939. Watson, Peter H. – Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada;
    940. Waumans, Yannick – CellCarta NV, Antwerp, Belgium;
    941. Webber, Mark – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    942. Weber, Karsten – German Breast Group, Neu-Isenburg, Germany;
    943. Wen, Hannah – Memorial Sloan Kettering Cancer Centre, USA;
    944. Werness, Bruce – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    945. Wernicke, Alejandra – Anatomical Pathology, Hospital Italiano de Buenos Aires;
    946. Wesseling, Jelle – Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands;
    947. Westenend, Pieter – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    948. Whitehouse, Ann – Histopathology, Sullivan Nicolaides, Australia;
    949. Wienert, Stephan – Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany;
    950. wightman, robert – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    951. Willaert, Katrien – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    952. Willard-Gallo, Karen – Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium;
    953. Williams, David – Anatomical Pathology, Austin Health, Heidelberg, Australia;
    954. Willis, Scooter – Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, USA;
    955. Wolff, Antonio – Breast Cancer Trials, Women’s Malignancies Disease Group , The Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA;
    956. Wu, Jenny – BMS;
    957. Xiang, Lu – Breast Surgery, the First Hospital of Jiaxing, China;
    958. Yamaguchi, Rin – Department of Pathology & Laboratory Medicine, Kurume University Medical Center, Fukuoka, Japan.;
    959. Yan, Linlin – Department of Scientific Research, Simcere Diagnostics Inc., China;
    960. Yang, Wentao – Department of Pathology, Fudan University Cancer Center, China;
    961. Yang, Wenxian – Aginome Scientific Pte Ltd., Xiamen, China;
    962. Yee, Laura – National Cancer Institute, Maryland, USA;
    963. Yoshikawa, Katsuhiro – Kansai Medical University Medical Center, Osaka, Japan;
    964. Yu, Clare – Department of Physics and Astronomy, University of California, Irvine, Irvine, CA, USA;
    965. Yu, Rongshan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    966. Yuan, Yinyin – Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
    967. Yuan, Zheng – Histogenex, China;
    968. Yuceyalcin, Tubay – WSK Medical, The Netherlands;
    969. YUKSEL, Seher – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    970. Zaakouk, Mohamed – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    971. ZAPATA, MARDELANGEL – Department of Pathology, Iren Sur, Peru;
    972. Zardavas, Dimitrios – Oncology Clinical Development, Bristol-Myers Squibb, Princeton, USA;
    973. Zha, Jiping – Translational Sciences, MedImmune, Gaithersberg, USA;
    974. zhang, weijie – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
    975. zhao, pin – Pathology, Huayin diagnostic center, Guangzhou, China;
    976. Ziai, James – Research Pathology, Genentech Inc., South San Francisco, USA;
    977. Zimmerman, Johannes – Scientific Director, Image Analysis, AstraZeneca Computational Pathology, Munich Area, Germany;
    978. Zimovjanova, Martina – Oncology, General Teaching hospital Prague, Czech Republic;
    979. Zin, Reena Md. – Department of Pathology, Faculty of Medicine, UKM, Kuala Lumpur , Malaysia;
    980. Zolota, Vasiliki – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org;
*Update in progress. Please email roberto@salgado.be for any changes.